Skip to main content
Summary of #EULAR2024 #ClinicalPearls

JAKi have expanding disease data
✅ #GCA w #UPA
✅ Awaiting data in #SLE w #UPA

Janet Pope Janetbirdope

2 years 2 months ago
Summary of #EULAR2024 #ClinicalPearls JAKi have expanding disease data ✅ #GCA w #UPA ✅ Awaiting data in #SLE w #UPA & #Deucravacitinib ✅Use in #JIA ✅No new safety signals @rheumnow @eular_org
It is almost four years since EULAR published its definition of difficult-to-treat (D2T) rheumatoid arthritis (RA) (1). This marked a formal recognition of the group of patients who, despite the advances in pharmacological therapy for RA, remain symptomatic.
Imaging in Axial Spondyloarthritis
Axial & Psoriatic Disease
EULAR 2024: New drugs for RA?

Abiprubart is an Abatacept distant relative, targeting T cell activation through a differ

Dr. John Cush RheumNow

2 years 2 months ago
EULAR 2024: New drugs for RA? Abiprubart is an Abatacept distant relative, targeting T cell activation through a different target/molecular interaction (CD40/CD154). https://t.co/3wAGjfCdcN https://t.co/2YK2OeIVZK
RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb & UCB.

Dr. John Cush RheumNow

2 years 2 months ago
RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb & UCB. All content is chosen by RheumNow & its faculty.
EULAR Daily Recap: Day 3
RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. Al

Dr. John Cush RheumNow

2 years 2 months ago
RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty.
How many #autoantibodies
Does one need in
#rheumatoid #arthritis

Need 4 citrullinated peptides
Covers off
97% of IgG

Janet Pope Janetbirdope

2 years 2 months ago
How many #autoantibodies Does one need in #rheumatoid #arthritis Need 4 citrullinated peptides Covers off 97% of IgG CVP2 ACPAs #EULAR2024 @RheumNow @eular_org https://t.co/LNFGuFXGrC
Once in remission with
#rituximab in #GPA
How long to resize
500 mg q6 mo for
4 years?
?longer
?less
#EULAR2024 @eular

Janet Pope Janetbirdope

2 years 2 months ago
Once in remission with #rituximab in #GPA How long to resize 500 mg q6 mo for 4 years? ?longer ?less #EULAR2024 @eular_org @RheumNow https://t.co/G4kU3v81je
Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find a

Peter Nash drpnash

2 years 2 months ago
Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find any pathology outside of joints, remote SpAologists, no longer physicians - easy to train rheumatology nurses to do our jobs @RheumNow #EULAR2024
EULAR 2024 Highlights: Saturday’s Recap with RheumNow https://t.co/BlOsbr9lYB

Dr. John Cush RheumNow

2 years 2 months ago
EULAR 2024 Highlights: Saturday’s Recap with RheumNow https://t.co/BlOsbr9lYB
#EULARBEST
RCT of #upadacitinib in #GCA

It works to steroid spare
15 mg > 7.5 mg in outcomes
Both >>placebo

Janet Pope Janetbirdope

2 years 2 months ago
#EULARBEST RCT of #upadacitinib in #GCA It works to steroid spare 15 mg > 7.5 mg in outcomes Both >>placebo Ethically PBO had slower #prednisone taper Similar to #TCZ data What to choose in GCA IL6i IL17i JAKi @eular_org @RheumNow LBA0001 https://t.co/gy0TEiHxjo
×